FDA Inspection 937661 — Zhejiang Dayang Biotech Group Co. Ltd.
The FDA completed an inspection of Zhejiang Dayang Biotech Group Co. Ltd. on July 10, 2015 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 10, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)